Innovations in Licensing of STM Content--and Why This Helps Predict the Future of Your Business
Is STM on your radar? If not, you better start paying attention. When it comes to creating data-driven content and new ways to package and sell that content, the Science, Technology and Medical vertical is typically far ahead of other industries. Hear how major players in STM are changing how they go to market, how this will trickle down to the rest of the licensing world—and how you get a jump on your competition.
Ed Colleran, Partner, Triumvirate Content Consulting
Steven Heffner, Director of Product Strategy, Wolters Kluwer
Robert McKinney, Jr., Director of Commercial Licensing & Global Business Development, The New England Journal of Medicine